|
2025
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
2024
|
G/S
|
Pharmaceutical preparations and substances; Medicinal preparations and substances; Vaccines. |
|
|
G/S
|
Providing medical information in the field of hemophilia and the treatment of hemophilia. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brai... |
|
|
G/S
|
providing medical information in the field of ulcerative colitis and inflammatory bowel disease, ... |
|
|
G/S
|
Downloadable mobile applications for tracking injections for the treatment and prevention of endo... |
|
|
G/S
|
Radio-frequency identification (RFID) labels to enable tracking of pharmaceutical preparations. |
|
|
G/S
|
Providing medical information in the field of hemophilia and the treatment of hemophilia |
|
|
Invention
|
Pyrido[4,3-d]pyrimidine compounds.
The invention relates to compounds of Formula (I)-(III) and p... |
|
|
G/S
|
Medical information services, namely, providing information related to hemophilia |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of endocrine diseases and disorders ... |
|
|
G/S
|
Providing insurance information about medication insurance coverage and insurance payer policies.... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastroint... |
|
|
Invention
|
Systems and methods for performing biological assays.
Systems and methods for performing biologi... |
|
|
Invention
|
Metabolites of glp1r agonists.
The present invention provides compounds of Formula XA-1, XA-2, X... |
|
|
Invention
|
Coronavirus antigen variants. The present disclosure provides isolated immunogenic polypeptides c... |
|
|
G/S
|
Medical information services, namely providing information in the fields of biopharmaceuticals, h... |
|
|
Invention
|
Lipid nanoparticles comprising polymer-conjugated lipids and uses thereof. Compounds are provided... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Amphiphilic tlr7/8 adjuvants and uses thereof. The invention relates to compounds of Formula (I) ... |
|
|
G/S
|
Providing medical information in the field of cancer diagnosis; providing medical information in ... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
Invention
|
High drug loading formulations of encorafenib. This invention relates to high drug loading formul... |
|
|
Invention
|
Combinations of estrogen receptor degraders and cdk7 inhibitors for the treatment of cancer. Disc... |
|
|
Invention
|
Solid forms of (r)-n-(3-(7-methyl-1h-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1... |
|
|
Invention
|
Treatment of multiple myeloma. Provided herein are methods of treatment of cancers, specifically ... |
|
|
Invention
|
Method for stabilizing rna. The invention relates to RNA molecules encoding an E. coli fimbrial H... |
|
|
Invention
|
Process and intermediates for preparing ibuzatrelvir. The present disclosure is directed to proce... |
|
|
Invention
|
Pediatric dosing regimens comprising a fusion inhibitor for the treatment of rsv. The invention r... |
|
|
Invention
|
S)-2-oxopyrrolidin-3-yl]ethyl}-4-(trifluoromethyl)-l-prolinamide and solvates thereof. The presen... |
|
|
Invention
|
Methods and modified dosing regimens comprising a cdk4 inhibitor for the treatment of cancer. The... |
|
|
Invention
|
Combinations of estrogen receptor degraders and cdk4 inhibitors. Disclosed herein are methods for... |
|
|
Invention
|
Anti-tl1a antibody therapeutic methods. The present disclosure provides methods and compositions ... |
|
|
Invention
|
Engineered rna polymerase variants. The present disclosure relates to engineered RNA polymerase p... |
|
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof. The... |
|
|
Invention
|
Varenicline formulations. In an embodiment, there is provided a varenicline formulation consistin... |
|
|
Invention
|
Methods of treating hepatic-only metastatic uveal melanoma. Provided herein is a method of treati... |
|
|
Invention
|
Antibodies specific for cd70 and their uses.
The present invention provides antibodies that spec... |
|
|
Invention
|
Lilrb1 and lilrb2 antibodies and methods of use thereof.
The invention is directed to Anti-LILRB... |
|
|
Invention
|
Improved cells and cell cultures. Cells having improved growth and related cell cultures are prov... |
|
|
Invention
|
Pyrido[4,3-d]pyrimidine compounds. The invention relates to compounds of Formula (I)-(III) and ph... |
|
|
Invention
|
Lilrb1 and lilrb2 antibodies and methods of use thereof. The invention is directed to Anti-LILRB1... |
|
|
Invention
|
Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof.
Described he... |
|
|
Invention
|
Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof. Described her... |
|
|
Invention
|
Novel 5-cycloproylquinoline derivatives as plpro inhibitors. The invention relates to compounds o... |
|
|
Invention
|
D]pyrimidine compounds. The invention relates to compounds of Formula (I)-(III) and pharmaceutica... |
|
|
Invention
|
Calicheamicin derivatives and antibody drug conjugates thereof.
The present invention is directe... |
|
|
Invention
|
Substituted indazole propionic acid derivative compounds and uses thereof as ampk activators. The... |
|
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the ... |
|
|
Invention
|
Modulators of sting (stimulator of interferon genes).
Provided herein are compounds of the gener... |
|
2023
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof.
Th... |
|
|
Invention
|
Display screen or portion thereof with graphical user interface |
|
|
Invention
|
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors.
The pres... |
|
2022
|
Invention
|
Wearable companion for detecting the cytokine release syndrome.
Embodiments disclosed herein may... |
|
|
Invention
|
Blister packaging for pharmaceuticals.
A blister package is disclosed herein. The blister packag... |
|
|
Invention
|
Digital medicine companion for treating and managing skin diseases.
A digital medicine companion... |
|
|
Invention
|
Combination therapy comprising a pkc inhibitor and a c-met inhibitor.
Provided herein is a combi... |
|
|
Invention
|
Methods and dosing regimens comprising a cdk2 inhibitor and a cdk4 inhibitor for treating cancer.... |
|
|
Invention
|
Cdk4 inhibitor for the treatment of cancer.
The disclosure provides a method of treating cancer ... |
|
|
Invention
|
Crystalline form of azalactam compound.
This disclosure relates to a crystalline form of 4-[(1R)... |
|
|
Invention
|
Cd21 antibodies and uses thereof.
Provided herein are anti-CD21 antibodies or antigen binding fr... |
|
2021
|
Invention
|
Pharmaceutical product container |
|
2020
|
Invention
|
Treatment of hidradenitis with jak inhibitors.
There are methods for treating hidradenitis suppu... |
